Dermatomyositis is a rare inflammatory disease ... Hence, Dr Himanshi Chaudhary insisted that early diagnosis and treatment are crucial in managing JDM and preventing complications such as ...

Early detection of ILD,given the risk of rapid deterioration and best treatment guidelines are of extreme importance ... References [1]Nombel A, Fabien N, Coutant F. Dermatomyositis With Anti-MDA5 ...

As demonstrated in this case, and accompanying literature review, dermatomyositis is a rare complication of cervical cancer but should be considered as urgent treatment of the underlying ... produced ...

Early recognition is important because treatment with glucocorticoids with or without cytotoxic drugs, particularly ...

Patients often get better with treatment. But while taking these medications, it's important to be careful to avoid getting ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

Cartesian Therapeutics said it has received rare pediatric disease designation from the U.S. Food and Drug Administration for its Descartes-08 treatment of juvenile dermatomyositis.

Melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (DM ... of myositis and succumbed to their illness despite aggressive medical treatment.

Descartes-08, Cartesian’s lead mRNA cell therapy candidate, is an autologous mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T) product candidate targeting B-cell maturation antigen ...

Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Participant eligibility includes age, gender, type and stage of disease, and ...

Objectives Risk prediction for patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD) is challenging due to heterogeneity in the ...

Denileukin diftitox, an IL-2-receptor-directed cytotoxin, has been added to the NCCN guidelines for the treatment of adult ...